OnKure Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for OnKure Therapeutics, Inc. (OKUR) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Current Assets
Cash and Cash Equivalents110.76102.9611.54147.67
Cash & Short-Term Investments110.76102.9611.54147.67
Accounts Receivable0.000.000.000.00
Inventory0.000.000.000.00
Other Current Assets2.2411.432.083.00
Total Current Assets113.00106.6213.62153.73
Non-Current Assets
Property, Plant & Equipment (Net)1.800.732.050.21
Other Non-Current Assets0.110.080.330.08
Total Non-Current Assets1.900.812.380.29
Total Assets114.91107.4416.00154.02
Current Liabilities
Accounts Payable2.9717.852.526.20
Short-Term Debt0.540.000.000.00
Accrued Liabilities3.853.662.870.00
Other Current Liabilities7.030.000.000.00
Total Current Liabilities10.5318.185.546.20
Non-Current Liabilities
Long-Term Debt0.550.640.490.00
Other Non-Current Liabilities0.000.000.000.17
Total Non-Current Liabilities0.550.6564.880.61
Total Liabilities11.0818.836.036.81
Stockholders' Equity
Common Stock0.000.000.000.00
Retained Earnings-154.72-218.47-57.07-84.69
Additional Paid-in Capital258.55307.072.66231.90
Shares Outstanding13.3513.3413.340.00
Total Stockholders' Equity103.8388.619.97147.21
Total Liabilities & Equity114.91107.4416.00154.02